Dongliang Guan

Title: Innovations and Contributions of Dongliang Guan

Introduction

Dongliang Guan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating bacterial infections. With a total of 4 patents to his name, his work has garnered attention in the scientific community.

Latest Patents

One of his latest patents is focused on vancomycin derivatives, which includes a preparation method, pharmaceutical composition, and their use in treating bacterial infections, especially those caused by Gram-positive bacteria. This innovation provides a class of vancomycin derivatives with a specific structure and pharmaceutically acceptable salts, aimed at enhancing treatment options for bacterial infection diseases.

Another notable patent involves C-aryl glucoside derivatives, detailing their preparation processes and pharmaceutical uses. These derivatives are particularly significant as sodium-dependent glucose cotransporter (SGLT)-1 inhibitors, which can play a crucial role in therapeutic applications.

Career Highlights

Dongliang Guan has worked with reputable companies in the pharmaceutical industry, including Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Dongliang has collaborated with notable colleagues such as Fanglong Yang and Peng Cho Tang. These partnerships have likely facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Dongliang Guan's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for bacterial infections, showcasing the importance of innovation in healthcare.